COSCIENS Biopharma Inc. Decrease Through Classified As Held For Sale Goodwill
COSCIENS Biopharma Inc. (CSCIF) reported Decrease Through Classified As Held For Sale Goodwill of $1.77 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-29.
Discontinued › Notes
ifrs-full:DecreaseThroughClassifiedAsHeldForSaleGoodwill · last filed 2022-03-29
- COSCIENS Biopharma Inc. decrease through classified as held for sale goodwill for the quarter ending 2020-06-30 was $412.00K.
- COSCIENS Biopharma Inc. decrease through classified as held for sale goodwill for the quarter ending 2020-03-31 was $720.00K.
| Period end | Decrease Through Classified As Held For Sale Goodwill 3 month | Decrease Through Classified As Held For Sale Goodwill 6 month | Decrease Through Classified As Held For Sale Goodwill 12 month |
|---|---|---|---|
| 2021-12-31 | $1.77M 20-F · filed 2022-03-29 | ||
| 2020-12-31 | $1.62M 40-F/A · filed 2021-03-29 | ||
| 2020-06-30 | $412.00K derived: 6-K 6 month − 6-K/A 3 month · filed 2020-08-06 | $1.13M 6-K · filed 2020-08-06 | |
| 2020-03-31 | $720.00K 6-K/A · filed 2020-05-11 | ||
| 2019-12-31 | $1.10M 20-F · filed 2020-03-31 |